MRSA Bacteria Popping Up in American Hospitals
November 25, 2009
Boston (DbTechNo) - Results of a new US study find that MRSA bacteria is being found in more hospitals than years past.
This is a very dangerous type of bacteria, which can result in fatalities if patients become infected.
The danger with this type of bacteria is that it is drug resistant, meaning that it does not respond to broad-spectrum antibiotics.
Outpatients are being diagnosed with MRSA bacteria at an alarming rate, up 7 fold from 1999 say the researchers.
They state that the high number of outpatients being diagnosed with the bacteria, may result in more in-patients being diagnosed, which would be a nightmare for all involved.
“What this is suggesting is that outpatients are a significant source of MRSA, especially community-associated MRSA strains,” said the study’s lead author, Eili Klein, a doctoral candidate at Princeton University and a researcher at Resources for the Future.
The study can be found in the December issue of Emerging Infectious Diseases.
Comments
2 Responses to “MRSA Bacteria Popping Up in American Hospitals”
All comments are moderated.
If your comment is approved, it will be posted within 24 hours
Breaking News
Lil Wayne to be Sentenced in Gun Possession CaseBoston (DbTechNo) - Rapper Lil Wayne will be sentenced today after pleading guilty to gun possession charges. The charges...
Autism Risk Increases in Children with Older MothersBoston (DbTechNo) - When it comes to the risk of a child developing autism a lot depends on the age of his or her mother...
Antidepressant Interfeers With Breast Cancer Drug tamoxifenBoston (DbTechNo) - The antidepressant drug paxil has been shown to interfeer with a leading breast cancer drug called tamoxifen. According...
STIMULATING IMMUNE FUNCTION TO DEFEAT HINI, MRSA, AND OTHER INFECTIOUS DISORDERS
Stimulating immune function to perform efficiently is the logical approach to defeating pathogens. Such stimulation is propagandized as unavailable, while in truth the remarkable immunostimulating properties of lithium and antidepressants were documented in 1981, when I published the first of nine reviews on the topic. A therapeutic claim is reinforced when the mechanism is known. Prostaglandins, when produced excessively, depress every component of immune function, and induce microbial replication. In the early nineteen-seventies, a colleague showed that antidepressants and lithium inhibit prostaglandins.
Lithium has immunostimulating, antiviral and antibacterial properties, antidepressants immunostimulating, antiviral, antibacterial, antiparasite, and fungicidal properties. Lithium is potentially effective for paronychia, chalazions, bacterial skin infections, urinary tract infections, canker sores, cold sores and genital herpes, antidepressants for canker sores, cold sores, and genital herpes. Evidence from various sources supports the use of antidepressants in T.B, malaria, and HIV; when antidepressants are added to antiretrovirals, they reduce HIV viral load to undetectable. Lithium has untapped potential in methicillin-resistant staphylococcal infections, (MRSA) hospital acquired infections (HAIs) sepsis, and pressure ulcers (bed sores). Once stimulated, a previously defective immune system should be able to eradicate or inactivate all pathogens.
There is concern at France’s Merieux Foundation that global warming will induce an upsurge in viral and other infections. Tuberculosis, now the #1 killer of the HIV infected, is developing resistance to standard treatment. With the threats posed by resistant T.B, migration to our shores of parasites never seen here before, and the emerging resistance of the malaria parasite to antimalarials, the availability of immunostimulation will be of evermore importance. In a 1983 review, I proposed that to stimulate immune function, an agent must have mood elevating properties. Over the past quarter of a century, I appealed to countless individuals and institutions to support the advance, none of which responded.
As lithium and antidepressants both prevent recurrences of flu’ like colds, one cannot be sure which to favor for HINI, lithium for some, antidepressants for others a possibility. A few doses of lithium, or an antidepressant, could sufficiently stimulate immune function, and reduce viral replication, as to return some of the stricken from the brink. A stimulated immune system would also be able to destroy super infection with bacteria or other viruses. People with well functioning immune systems are relatively invulnerable to pathogens, compared to people with defective immune function. Of the causes of defective immunity, one never mentioned is depression, although indices of immune function indicate that depression does so. Immunostimulation has vast humanitarian and economic potential, and if adopted and implemented would make a major contribution to health reform.
My research drew on clinical observation, and the studies of colleagues indexed in Current Contents, Medline and Pubmed. The contents of this article may be verified by searching these databases.
Julian Lieb, M.D
I am a retired, former Yale medical school psychiatry professor, and author or coauthor of forty- eight articles and ten books. The tenth, “Stimulating immune function to kill viruses” is in the Amazon system. .
As an ER MD I am seeing more community acquired MRSA infections, and increasing resistance to the more common antibiotics. Learn the signs and symptoms of MRSA at:
http://www.itriagehealth.com/disease/methicillin-resistant-staphylococcus-aureus-%28mrsa%29